期刊文献+

老年不稳定型心绞痛患者血清Angptl 2、Angptl 4的表达与冠状动脉病变的相关性研究 被引量:1

Correlation study between serum Angptl 2 and Angptl 4 levels in elderly patients with unstable angina and the degree of coronary artery disease
下载PDF
导出
摘要 目的分析老年不稳定型心绞痛(UAP)患者血清血管生成素样蛋白2(Angptl 2)、血管生成素样蛋白4(Angptl 4)的表达与冠状动脉病变的相关性。方法选择浙江省台州市中心医院2017年8月-2020年1月收治的192例老年UAP且经冠状动脉造影确诊存在冠状动脉病变的患者作为UAP组,另选取同期200例体检无冠状动脉病变的健康者作为对照组。ELISA法检测老年UAP患者血清Angptl 2、Angptl 4的表达,Pearson法分析Angptl 2、Angptl 4表达与Gensini评分的相关性。结果 UAP组血清Angptl 2表达高于对照组(P<0.01),Angptl 4表达低于对照组,差异均有统计学意义(P<0.01)。与冠状动脉轻度病变组比较,中度、重度病变组Angptl 2表达升高(P<0.01),Angptl 4表达降低(P<0.01);与冠状动脉中度病变组比较,重度病变组Angptl 2表达升高(P<0.01),Angptl 4表达降低,差异均有统计学意义(P<0.01)。血清Angptl 2表达与Gensini评分呈正相关(r=0.477,P<0.01),血清Angptl 4表达与Gensini评分呈负相关(r=-0.309,P<0.01)。结论老年UAP患者中随着血清Angptl 2表达的升高和Angptl 4表达的降低,预示疾病进展,血清Angptl 2、Angptl 4表达水平可间接反映患者冠状动脉病变的严重程度。
作者 颜丽丽 陈磊 谢青龙 YAN Lili;CHEN Lei;XIE Qinglong
出处 《浙江实用医学》 2020年第3期162-164,共3页 Zhejiang Practical Medicine
  • 相关文献

参考文献5

二级参考文献32

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2166

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部